Announced Wed, 22 Jul · 12:08 IST
Venus Remedies publishes Q1 FY27 unaudited results in newspapers
Compliance View source PDF
VENUSREM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-7.2%1-day move
₹1778.50
prior close
₹1715.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.9-0.9-1.5-0.9-7.2-7.4-11.6———————
Up moveDown movePending
AI summary
Venus Remedies Limited has submitted the newspaper publication of its unaudited financial results for the quarter ended 30 June 2026, as required under SEBI LODR Regulation 30. The detailed financial numbers were not clearly legible in the filing document. This is a routine compliance disclosure.
Likely market impact
Routine regulatory compliance filing. No immediate material impact on share price expected.